<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fphar.2017.00297</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Neuronal Voltage Gated Potassium Channels May Modulate Nitric Oxide Synthesis in Corpus Cavernosum</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Senbel</surname> <given-names>Amira M.</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/400165/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Abd Elmoneim</surname> <given-names>Heba M.</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/403016/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sharabi</surname> <given-names>Fouad M.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Mohy El-Din</surname> <given-names>Mahmoud M.</given-names></name>
</contrib>
</contrib-group>
<aff><institution>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University</institution> <country>Alexandria, Egypt</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Paulo Correia-de-S&#x000E1;, University of Porto, Portugal</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Javier Angulo, Hospital Universitario Ram&#x000F3;n y Cajal, Spain; Simon James Gibbons, Mayo Clinic Minnesota, United States</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Amira M. Senbel <email>senbelamira&#x00040;alexpharmacy.edu.eg</email></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>05</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>297</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>05</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Senbel, Abd Elmoneim, Sharabi and Mohy El-Din.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Senbel, Abd Elmoneim, Sharabi and Mohy El-Din</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Potassium channels (K<sup>&#x0002B;</sup>Ch) in corpus cavernosum play an important role in the regulation of erection. Nitric oxide (NO) acts through opening of K<sup>&#x0002B;</sup>Ch leading to hyperpolarization and relaxation.</p>
<p><bold>Aim :</bold> This study aims to update knowledge about the role of voltage-gated K<sup>&#x0002B;</sup>Ch (K<sub>V</sub>) channels in erectile machinery and investigate their role in the control of NO action &#x00026;/or synthesis in the corpus cavernosum.</p>
<p><bold>Methods :</bold> Tension studies using isolated rabbit corpus cavernosum (CC) strips and rat anococcygeus muscle were conducted. Results are expressed as mean &#x000B1; SEM.</p>
<p><bold>Results :</bold> Electric field stimulation (EFS, 2&#x02013;16 Hz) evoked frequency-dependent relaxations of the PE (phenylephrine)-precontracted CC strips. At 2 Hz, EFS-induced relaxation amounted to 73.17 &#x000B1; 2.55% in presence 4-AP (10<sup>&#x02212;3</sup> M) compared to 41.98 &#x000B1; 1.45% as control. None of the other selective K<sup>&#x0002B;</sup>Ch blockers tested inhibited EFS-induced relaxation. 4-AP (10<sup>&#x02212;3</sup>M) significantly attenuated ACh-induced relaxation of rabbit CC where dose-response curve was clearly shifted upward, and attenuated SNP- induced relaxation, for example, to 49.28 &#x000B1; 4.52% compared to 65.53 &#x000B1; 3.01% as control at 10<sup>&#x02212;6</sup> M SNP. The potentiatory effect of 4-AP on EFS was abolished or reversed in presence of N<sup><italic>G</italic></sup>-nitro-L-arginine (L-NNA, non-selective nitric oxide synthase inhibitor, 10<sup>&#x02212;5</sup>M, and 2 &#x000D7; 10<sup>&#x02212;4</sup>M). Same results were observed in rat anococcygeus muscle which is a part of the erectile machinery in rats.</p>
<p><bold>Conclusion :</bold> This study provides evidence for the presence of prejunctional voltage-gated K<sup>&#x0002B;</sup>Ch in CC, the blockade of which may increase the neuronal synthesis of NO.</p></abstract>
<kwd-group>
<kwd>nitric oxide</kwd>
<kwd>potassium channels</kwd>
<kwd>erection</kwd>
<kwd>corpus cavernosum</kwd>
<kwd>voltage- gated potassium channels</kwd>
<kwd>4-amino pyridine</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="50"/>
<page-count count="8"/>
<word-count count="6332"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Penile erection is the end result of a complex neuro-vascular process in which nerves, endothelium of sinusoids and blood vessels, and smooth muscle cells in the target organ are involved (Andersson, <xref ref-type="bibr" rid="B1">2011</xref>). Penile erection is achieved by dilatation of penile arteries and relaxation of the trabecular smooth muscles located in the corpus cavernosum (CC) with subsequent compression of penile veins (Gratzke et al., <xref ref-type="bibr" rid="B17">2010</xref>). The main mediator of this smooth muscle cell relaxation in the penis is nitric oxide (NO), which is synthesized by eNOS and nNOS, in nitrergic nerves, endothelial cells, and cavernosal smooth muscle cells. The increased NO production induces activation of sGC, increased cGMP levels, and activation of PKG (Musicki et al., <xref ref-type="bibr" rid="B39">2009</xref>). Protein kinase G phosphorylates several key target proteins, including ion channels, ion pumps, and enzymes; all involved in the control of intracellular calcium level. Among these target ion channels are K<sup>&#x0002B;</sup> channels (Lin et al., <xref ref-type="bibr" rid="B34">2005</xref>; Prieto, <xref ref-type="bibr" rid="B41">2008</xref>). Phosphorylation of K<sup>&#x0002B;</sup> channels by PKG leads to their activation with subsequent hyperpolarization and relaxation of corporal smooth muscle cells (Christ, <xref ref-type="bibr" rid="B5">2000</xref>, <xref ref-type="bibr" rid="B6">2002</xref>; Lee, <xref ref-type="bibr" rid="B30">2000</xref>; Archer, <xref ref-type="bibr" rid="B3">2002</xref>).</p>
<p>Four major types of K<sup>&#x0002B;</sup> channels are expressed in smooth muscles: large conductance Ca<sup>2&#x0002B;</sup>-activated (BK<sub>Ca</sub>), ATP-sensitive (K<sub>ATP</sub>), inward rectifier (Kir) and voltage-gated (K<sub>V</sub>) (Stott et al., <xref ref-type="bibr" rid="B44">2014</xref>). (BK<sub>Ca</sub>) channels have been characterized in the CC smooth muscle of several species including rabbits, where they are thought to be important regulators of smooth muscle tone (Fan et al., <xref ref-type="bibr" rid="B13">1995</xref>; Wang et al., <xref ref-type="bibr" rid="B47">2000</xref>; Malysz et al., <xref ref-type="bibr" rid="B37">2001</xref>; Werner et al., <xref ref-type="bibr" rid="B48">2005</xref>; Hannigan et al., <xref ref-type="bibr" rid="B19">2016</xref>). Electrophysiological characterization has demonstrated the expression of K<sub>ATP</sub> channels in corporal smooth muscle cells, which induce muscle relaxation upon channel activation (Holmquist et al., <xref ref-type="bibr" rid="B21">1990</xref>; Lee et al., <xref ref-type="bibr" rid="B31">1999</xref>; Insuk et al., <xref ref-type="bibr" rid="B23">2003</xref>). On the other hand, activation of Kir channels have been implicated in mediating part of the relaxant response to <italic>Schisandra chinensis</italic> extract in rabbit CC (Han et al., <xref ref-type="bibr" rid="B18">2012</xref>). Furthermore, the endothelium- independent relaxation of rat CC induced by taurine (Dalaklioglu-Tasatargil, <xref ref-type="bibr" rid="B10">2013</xref>) and resveratrol (Dalaklioglu and Ozbey, <xref ref-type="bibr" rid="B9">2014</xref>) was proved to depend in part on Kir channels activation. Evidence for the presence of K<sub>V</sub> channels in rabbit CC have been provided by Malysz et al. (<xref ref-type="bibr" rid="B37">2001</xref>), where the authors reported at least two types of smooth muscle cells in the CC, one with predominant K<sub>V</sub> channels and the other with predominant (BK<sub>Ca</sub>) channels. In addition, the K<sub><italic>V</italic></sub> channels appeared to be important for the regulation and control of the membrane potential in cavernous smooth muscle cells (Malysz et al., <xref ref-type="bibr" rid="B37">2001</xref>, <xref ref-type="bibr" rid="B36">2002</xref>).</p>
<p>Voltage-gated K<sup>&#x0002B;</sup> channels comprise the largest and most diverse family among human K<sup>&#x0002B;</sup> channels, with 12 known subfamilies (KV1&#x02013;KV12) (Wulff et al., <xref ref-type="bibr" rid="B49">2009</xref>; Lily Jan et al., <xref ref-type="bibr" rid="B33">2016</xref>). These channels are generally activated by depolarization, therefore they tend to play roles in repolarizing membranes in nerve and muscle cells, thus controlling action potential frequency and duration. In vascular smooth muscle cells, vasoconstrictors stimulate the G-protein-coupled receptors, which cause phospholipase C/ diacylglycerol activation and consequently, activate PKC that induce K<sub>V</sub> channel inhibition. Vasodilators stimulate the production of cAMP and cGMP, which in turn increase K<sub>V</sub> channel activity through the stimulation of PKA and PKG respectively (Ko et al., <xref ref-type="bibr" rid="B27">2010</xref>). K<sub>V</sub> channels expression has been detected in vascular smooth muscle cells, where they limit membrane depolarization, vasoconstriction, and maintain resting vascular tone (Ko et al., <xref ref-type="bibr" rid="B26">2008</xref>). The major K<sub>V</sub> channels expressed in the vasculature are KV1.2, KV1.5, KV2.1, and KV7.4/7.5. Their distribution varies considerably with vascular bed, and there is some controversy over their relative contribution to the regulation of the resting membrane potential (Humphries and Dart, <xref ref-type="bibr" rid="B22">2015</xref>). As for the potential role of K<sub>V</sub> channels on nerve cells, limited data is available from peripheral system. In 2016, blockade of K<sub>V</sub> channels by 4-aminopyridine was proved to increase GABA and glutamate release in midbrain (Li et al., <xref ref-type="bibr" rid="B32">2016</xref>). Same observation was reported in guinea pig cerebrocortical synapses by Tibbs et al. (<xref ref-type="bibr" rid="B45">1989</xref>) and by Schnee and Brown (<xref ref-type="bibr" rid="B43">1998</xref>) in rat hippocampus (Schnee and Brown, <xref ref-type="bibr" rid="B43">1998</xref>). In general, altered K<sub>V</sub> channel expression and function is related to pathophysiological conditions such as systemic arterial hypertension, hypoxic pulmonary vasoconstriction, pulmonary arterial hypertension (Ko et al., <xref ref-type="bibr" rid="B27">2010</xref>) and Parkisonism (Luca and Singer, <xref ref-type="bibr" rid="B35">2013</xref>).</p>
<p>Little is known about the role of K<sub>V</sub> channels in erectile function (Archer, <xref ref-type="bibr" rid="B3">2002</xref>). Although K<sub>V</sub> channels are present and functional in CC (Christ et al., <xref ref-type="bibr" rid="B7">1993</xref>; Malysz et al., <xref ref-type="bibr" rid="B37">2001</xref>; Werner et al., <xref ref-type="bibr" rid="B48">2005</xref>), their role in erection is not well elucidated. In human and mouse CC, both the delayed rectifier and the fast transient A K<sup>&#x0002B;</sup> currents have been observed (Christ et al., <xref ref-type="bibr" rid="B7">1993</xref>; Werner et al., <xref ref-type="bibr" rid="B48">2005</xref>) while only the delayed rectifier current have been detected in rabbit CC. Delayed rectifier K<sup>&#x0002B;</sup> channels appear to be important for the regulation and control of the membrane potential in cavernous smooth muscle cells (Malysz et al., <xref ref-type="bibr" rid="B37">2001</xref>). In CC, KV2, and KV7 was shown to contribute to the voltage-dependent K<sup>&#x0002B;</sup> currents (Malysz et al., <xref ref-type="bibr" rid="B36">2002</xref>; Jepps et al., <xref ref-type="bibr" rid="B24">2016</xref>). Targeting K<sup>&#x0002B;</sup> channels can be considered a viable option for developing a treatment for ED that bypasses the NO/cGMP system and thus overcomes one of the major drawbacks of PDE5 inhibitors (Gopalakrishnan and Shieh, <xref ref-type="bibr" rid="B16">2004</xref>; Hannigan et al., <xref ref-type="bibr" rid="B19">2016</xref>).</p>
<p>Unjustifiably, most of the studies conducted to investigate K<sup>&#x0002B;</sup> channels in the CC considered the (BK<sub>Ca</sub>) and K<sub>ATP</sub> channels the most physiologically relevant (Lee, <xref ref-type="bibr" rid="B30">2000</xref>; Andersson, <xref ref-type="bibr" rid="B1">2011</xref>) and neglected the role of K<sub>V</sub> channels in erection. Therefore, little is known about the role of K<sub>V</sub> channels in erectile function<bold>;</bold> the current study thus aimed first at updating the knowledge about the effect of K<sub>V</sub> channels in CC and secondly, to understand their role in NO action and/or synthesis.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Chemicals</title>
<p>The chemicals used were 4-aminopyridine (4-AP), Atropine, Acetylcholine (ACh), Barium chloride (BaCl<sub>2</sub>), Glibenclamide, Guanethidine, N<sup>w</sup> nitro-L-arginine (L-NNA), Phenylephrine (PE), Sodium nitroprusside (SNP), and Tetraethylammonium (TEA); all purchased from Sigma. All chemicals were dissolved in saline except Glibenclamide that was dissolved in polyethylene glycol (PEG) 400.</p>
</sec>
<sec>
<title>Animals</title>
<p>Adult sexually mature male New Zealand White rabbits weighing 2.5&#x02013;3 kg and male albino rats weighing 250&#x02013;300 g were used. The animals were obtained from the Faculty of Pharmacy Alexandria University Animal House. All protocols adhere to international Animal Care and Use guidelines and approved by Faculty of Pharmacy&#x02014;Alexandria University ethical committee (Protocol number ACUC 16/4).</p>
</sec>
<sec>
<title>Organ bath experiments</title>
<sec>
<title>The isolated rabbit corpus cavernosum</title>
<p>After rabbit exsanguination, the penis were excised rapidly and placed in Krebs solution at 4&#x000B0;C. A ventral incision was made on the right and left corpora, the tunica was dissected and the rabbit CC tissue was exposed. The corpora were dissected and subsequently studied in organ chambers. Strips of rabbit CC were tied at each end with cotton threads and mounted in a 25 ml organ chamber. Tissue baths containing Krebs solution were kept at 37&#x000B0;C and constantly bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. Before the start of the experiment, atropine (1 &#x000D7; 10<sup>&#x02212;6</sup>M) and guanethidine (5 &#x000D7; 10<sup>&#x02212;6</sup>M) were added to the organ bath to block muscarinic receptors and prevent the release of norepinephrine, respectively, during subsequent EFS. The upper part of each strip was attached to a force displacement transducer (Grass FT-03), which was connected through an MLAC11 Grass adapter cable to a computerized data acquisition system with Lab Chart-7 pro software (Power Lab 4/35, model ML 866/P; AD Instrument Pty Ltd, Castle Hill, Australia). The initial resting tension was 1 g. The preparation was left to equilibrate for 60 min. Each strip was submaximally contracted with PE (3 &#x000D7; 10<sup>&#x02212;6</sup> M). After the PE contractile response has stabilized, relaxation responses to different treatments were recorded in a cumulative fashion, or subjected to EFS-induced relaxation at supramaximal voltage (0.8 mspulse duration) using sequential frequencies of 2, 4, 8, and 16 Hz delivered as 10 s. trains. The relaxation responses were assessed as a percentage of the PE-induced contractile response. A time-matched control was performed regularly by adding saline (or PEG400 in case of glibenclamide) instead of the test drug to ensure stability of response along the duration of the experiment. Neither saline nor PEG400 in the volume added to the organ bath (0.8%) showed any variation in tone or response curves.</p>
</sec>
<sec>
<title>The isolated rat anococcygeus muscle</title>
<p>The muscle was prepared using male albino rats weighing 250&#x02013;300 g according to the method described in 1972 by Gillespie (<xref ref-type="bibr" rid="B15">1972</xref>). The abdomen was opened and the bladder and the urethra were removed, the pelvis was raised with forceps and split along the midline using a pair of scissors. The bone was forced apart to reveal the terminal colon. The colon was lifted and the surrounding connective tissue was removed carefully toward the anus until the two anococcygeus muscles could be identified. The muscles arise from the vertebrae and can be followed to an angle to their point of meeting over the terminal colon. Each muscle was cleared from the surrounding connective tissue, tied at each end with cotton threads and mounted in a 25 ml organ chamber containing Krebs solution kept at 37&#x000B0;C and constantly bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. The initial resting tension was 1 g. The preparation was left to equilibrate for 30 min. EFS-induced relaxation was computed at supramaximal voltage (0.8 ms pulse duration) using sequential frequencies of 2, 4, 8, and 16 Hz delivered as 10 s. trains. Same data acquisition system was used as above-mentioned.</p>
</sec>
</sec>
<sec>
<title>Statistical analysis</title>
<p>The results obtained are expressed as mean &#x000B1; SEM. Throughout the manuscript, numbers between parentheses indicate number of animals. The student-<italic>t</italic>-test was used for the analysis of paired/unpaired data whenever applies. The analysis of variance (ANOVA) followed by Bonferroni&#x00027;s post-test was used for multiple comparisons. The criterion for statistical significance was set at <italic>p</italic> &#x0003C; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>Effect of potassium channel blockade on corpus cavernosum relaxation <italic>In vitro</italic></title>
<p>Strips of rabbit CC showed contractile responses induced by PE (3 &#x000D7; 10<sup>&#x02212;6</sup> M). Application of EFS elicited a transient frequency dependent relaxation response that increased in magnitude over a range of 2&#x02013;16 Hz. 4-AP (10<sup>&#x02212;3</sup> M) significantly enhanced the EFS-induced relaxation responses of rabbit CC. A tracing is represented in Figure <xref ref-type="fig" rid="F1">1</xref> showing the effect of 4-AP (10<sup>&#x02212;3</sup> M) on EFS-induced relaxation of rabbit CC. At 2 Hz, EFS-induced relaxation amounted to 73.17 &#x000B1; 2.55% in presence 4-AP (10<sup>&#x02212;3</sup> M) compared to 41.98 &#x000B1; 1.45% as control Figure <xref ref-type="fig" rid="F1">1</xref>.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Electric field stimulation-induced relaxation of phenylephrine precontracted rabbit corpus cavernosum in absence and in presence of 4-aminopyridine (4-AP, 10<sup><bold>&#x02212;3</bold></sup> M)</bold>. Results are expressed as mean &#x000B1; SEM of 6 animals. <sup>&#x0002A;</sup>Denotes significant difference compared to control at the level of <italic>P</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fphar-08-00297-g0001.tif"/>
</fig>
<p>Similar to 4-AP, TEA (10<sup>&#x02212;3</sup> M, non-selective concentration) potentiated EFS-induced relaxation. On the other hand, TEA (10<sup>&#x02212;5</sup> M, selective selective (BK<sub>Ca</sub>) blocker), glibenclamide (10<sup>&#x02212;5</sup> M, selective K<sub>ATP</sub> blocker) and BaCl<sub>2</sub> (10<sup>&#x02212;4</sup> M, selective Kir blocker) did not produce a significant change in the EFS-induced relaxation responses of rabbit CC Figure <xref ref-type="fig" rid="F2">2</xref>.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Electric field stimulation-induced relaxation of phenylephrine precontracted rabbit corpus cavernosum in absence and in presence of tetraethylammonium (TEA, 10<sup>&#x02212;3</sup> M), TEA (10<sup>&#x02212;5</sup> M), glibenclamide (10<sup>&#x02212;5</sup> M) or barium chloride (BaCl<sub>2</sub>, 10<sup>&#x02212;4</sup> M)</bold>. Results are expressed as mean &#x000B1; SEM. Values between parentheses indicate the number of animals. <sup>&#x0002A;</sup>Denotes significant difference than control at the level of <italic>P</italic> &#x0003C; 0.05. The representative tracings attached show the effect of TEA (10<sup>&#x02212;3</sup> M, upper panel) and TEA (10<sup>&#x02212;5</sup> M, lower panel).</p></caption>
<graphic xlink:href="fphar-08-00297-g0002.tif"/>
</fig>
<p>Using PE (3 &#x000D7; 10<sup>&#x02212;6</sup> M) precontracted rabbit CC strips, a dose response curve for ACh (10<sup>&#x02212;8</sup>&#x02013;10<sup>&#x02212;3</sup> M) or SNP (10<sup>&#x02212;8</sup>&#x02013;10<sup>&#x02212;4</sup> M) was constructed. 4-AP (10<sup>&#x02212;3</sup>M) significantly attenuated ACh-induced relaxation of rabbit CC where concentration-response curve was clearly shifted upward Figure <xref ref-type="fig" rid="F3">3A</xref>. Similarly, 4-AP (10<sup>&#x02212;3</sup>M) significantly attenuated SNP- induced relaxation, for example, to 49.28 &#x000B1; 4.52% compared to 65.53 &#x000B1; 3.01% as control at 10<sup>&#x02212;6</sup> M SNP (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>(A)</bold> Acetylcholine (ACh)-induced relaxation of phenylephrine precontracted rabbit corpus cavernosum in absence and in presence of 4-aminopyridine (4-AP, 10<sup>&#x02212;3</sup> M). Results are expressed as mean &#x000B1; SEM of 8 animals. <sup>&#x0002A;</sup>Denotes significant difference compared to control at the level of <italic>P</italic> &#x0003C; 0.05. <bold>(B):</bold> Sodium nitroprusside (SNP)-induced relaxation of phenylephrine precontracted rabbit corpus cavernosum in absence and in presence of 4-aminopyridine (4-AP, 10<sup>&#x02212;3</sup> M). Results are expressed as mean &#x000B1; SEM of 9 animals.<sup>&#x0002A;</sup>Denotes significant difference compared to control at the level of <italic>P</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fphar-08-00297-g0003.tif"/>
</fig>
</sec>
<sec>
<title>Interaction between potassium channels blockade and nitric oxide synthesis</title>
<sec>
<title>Effect of tetraethylammonium (10<sup>&#x02212;3</sup>M) and 4-aminopyridine (10<sup>&#x02212;3</sup>M) on electric field stimulation-induced relaxation in presence of L-NNA in rabbit corpus cavernosum</title>
<p>Two concentration of the non-selective NOS blocker L-NNA have been used in this set of experiments. Both concentration (10<sup>&#x02212;5</sup> M or 2 &#x000D7; 10<sup>&#x02212;4</sup> M) significantly inhibited EFS-induced relaxation responses at all frequencies tested. At 2 Hz L-NNA (10<sup>&#x02212;5</sup> M) and (2 &#x000D7; 10<sup>&#x02212;4</sup> M) resulted in inhibition of relaxation corresponding to 61.68 &#x000B1; 4.88% and 98.21 &#x000B1; 0.52 respectively.</p>
<p>TEA (10<sup>&#x02212;3</sup> M) added to the organ bath after 15-min incubation with L-NNA (10<sup>&#x02212;5</sup> M) caused inhibition of EFS-induced relaxations rather than potentiation (Figure <xref ref-type="fig" rid="F4">4</xref>). Figure <xref ref-type="fig" rid="F5">5</xref>, on the other hand, shows the same experiment using the selective K<sub>V</sub> blocker, 4-AP instead of TEA. 4-AP (10<sup>&#x02212;3</sup> M) in presence of L-NNA (10<sup>&#x02212;5</sup> M, incubated for 15 min) potentiated relaxations at 2 and 4 Hz only when compared to L-NNA effect alone. Its effect at 8 and 16 Hz was significantly lower than control indicating an inhibition of its potentiatory action (Figure <xref ref-type="fig" rid="F5">5A</xref>).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p><bold>Effect of tetraethylammonium (TEA, 10<sup>&#x02212;3</sup> M) on electric field stimulation- induced relaxation of phenylephrine precontracted rabbit corpus cavernosum in absence and presence of L-NNA (10<sup>&#x02212;5</sup> M)</bold>. Results are expressed as mean &#x000B1; SEM. Values between parentheses indicate the number of animals. <sup>&#x0002A;</sup>Denotes significant difference compared to TEA (10<sup>&#x02212;3</sup> M) at the level of <italic>p</italic> &#x0003C; 0.05. L-NNA was added to the organ bath 15 min. prior to the addition of TEA.</p></caption>
<graphic xlink:href="fphar-08-00297-g0004.tif"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><bold>Effect of 4-aminopyrdine (4-AP, 10<sup>&#x02212;3</sup> M) on electric field stimulation-induced relaxation of phenylephrine precontracted rabbit corpus cavernosum in absence and presence of L-NNA (10<sup>&#x02212;5</sup> or 2 &#x000D7; 10<sup>&#x02212;4</sup> M)</bold>. <bold>(A)</bold>: L-NNA (10<sup>&#x02212;5</sup>) was added to the organ bath 15 min prior to 4-AP addition. <bold>(B)</bold> L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M) was added to the organ bath 15 min prior to 4-AP addition. <bold>(C)</bold>: 4-AP and L-NNA (10<sup>&#x02212;5</sup> M) were added simultaneously to the organ bath. Results are expressed as mean &#x000B1; SEM. Values between parentheses indicate the number of animals. <sup>&#x0002A;</sup>Denotes significant difference compared to control at the level of <italic>p</italic> &#x0003C; 0.05. <sup>&#x00023;</sup>Denotes significant difference compared to L-NNA at the level of <italic>p</italic> &#x0003C; 0.05. <sup>$</sup>denotes significant difference compared to 4-AP (10<sup>&#x02212;3</sup> M) at the level of <italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fphar-08-00297-g0005.tif"/>
</fig>
<p>When the same protocol was repeated using a higher concentration of L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M, incubated for 15 min), the potentiatory effect of 4-AP on EFS- induced relaxation responses was masked at all frequencies tested. Relaxation induced by EFS after 4-AP showed no significance vs. L-NNA alone but was highly significantly lower than 4-AP effect and control as well (Figure <xref ref-type="fig" rid="F5">5B</xref>). For example, at 2 Hz, 4-AP (10<sup>&#x02212;3</sup> M) in presence of L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M) inhibited control EFS-induced relaxation by 78.50 &#x000B1; 6.43% (<italic>n</italic> &#x0003D; 7), compared to L-NNA alone which inhibited relaxation by 98.21 &#x000B1; 0.52% (<italic>n</italic> &#x0003D; 7). 4-AP alone potentiated the relaxation at the same frequency by 74.86 &#x000B1; 6.46% (<italic>n</italic> &#x0003D; 6). In another experimental design, 4-AP (10<sup>&#x02212;3</sup>M) and L-NNA (10<sup>&#x02212;5</sup> M) were added simultaneously to the organ bath (Figure <xref ref-type="fig" rid="F5">5C</xref>), the combination effect was significantly lower than control and 4-AP alone at 2,4,8, and 16 Hz.</p>
</sec>
<sec>
<title>Effect of 4-aminopyridine in absence and in presence of L-NNA on electric field stimulation-induced relaxation in presence of L-NNA in rat annococcygeus muscle</title>
<p>The isolated rat annococcygeus muscle showed contractile responses induced by PE (3 &#x000D7; 10<sup>&#x02212;6</sup> M). Application of EFS elicited a transient frequency dependent relaxation response that increased in magnitude over a range of 2&#x02013;16 Hz. Blockade of NOS by L- NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M) produced a reduction in the EFS-induced relaxation responses of rat anococcygeus muscle. At 2 Hz, the percentage relaxation induced by EFS in presence of L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M) was 1.16 &#x000B1; 0.34 compared to 22.99 &#x000B1; 3.4 as control. 4-AP (10<sup>&#x02212;4</sup> M) significantly enhanced the EFS-induced relaxation responses of rat annococcygeus muscle at 2 and 4 Hz causing a downward shift of the frequency response curve (Figure <xref ref-type="fig" rid="F6">6</xref>). In combination, and when 4-AP (10<sup>&#x02212;4</sup> M) was tested in presence of L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M, incubated for 15 min), its effect was totally abolished; it failed to potentiate relaxation induced by EFS at all frequencies tested. The frequency response curves in presence of L-NNA and the combination were almost superimposed and significantly lower than control (Figure <xref ref-type="fig" rid="F6">6</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p><bold>Effect of 4-aminopyrdine (4-AP, 10<sup>&#x02212;4</sup> M) on electric field stimulation-induced relaxation of phenylephrine precontracted rat anococcygeus muscle in absence and presence of L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M)</bold>. L-NNA (2 &#x000D7; 10<sup>&#x02212;4</sup> M) was added to the organ bath 15 min. prior to 4-AP addition. Results are expressed as mean &#x000B1; SEM. Values between parentheses indicate the number of animals. <sup>&#x0002A;</sup>Denotes significant difference compared to control at the level of <italic>p</italic> &#x0003C; 0.05. <sup>&#x00023;</sup>Denotes significant difference compared to L-NNA at the level of <italic>p</italic> &#x0003C; 0.05. <sup>$</sup>Denotes significant difference compared to 4-AP (10<sup>&#x02212;4</sup> M) at the level of <italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fphar-08-00297-g0006.tif"/>
</fig>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The selective role of different types of K<sup>&#x0002B;</sup> channels as modulators of penile erection is under investigated. Additionally, the relative contribution of the different types of K<sup>&#x0002B;</sup> channels to relaxations induced by NO-donors and ACh in rabbit CC has not been fully elucidated. Therefore, the first aim of the present study was to update the information about K<sub>V</sub> channels in CC and its contribution to the relaxations induced by ACh and NO in CC and secondly, to investigate the possible interactions between K<sub>V</sub> channels and NO in CC. In the present study, treatment of rabbit CC with the K<sub>V</sub> blocker, 4-AP, reduced the SNP and ACh-induced relaxations, an effect which indicates a role for K<sub>V</sub> channels in mediating NO action. The blockade of K<sub>V</sub> channels also attenuated SNP and ACh-induced relaxations in rat aorta (Satake et al., <xref ref-type="bibr" rid="B42">1997</xref>; Fiorim et al., <xref ref-type="bibr" rid="B14">2012</xref>; Dias et al., <xref ref-type="bibr" rid="B12">2014</xref>; Oliveira et al., <xref ref-type="bibr" rid="B40">2014</xref>). In line with these observations, K<sub>V</sub> channels have been implicated in the ACh-induced increase in ICP in cats as described by Moon et al. (<xref ref-type="bibr" rid="B38">1999</xref>). Moreover, 4-AP was reported as a possible allosteric modulator of muscarinic receptors in rat brain (Lai et al., <xref ref-type="bibr" rid="B29">1985</xref>). In contrast, in a study by Andre et al. (<xref ref-type="bibr" rid="B2">2003</xref>) 4-AP did not reduce the relaxations induced by ACh in rabbit CC. This discrepancy may be attributed to the difference in the conditions of the experiment where in the latter study, indomethacin was added to the Krebs solution. Based on the limited number of studies in literature and the opposing observations, it seems that the role of K<sub>V</sub> channels in ACh-evoked endothelium-dependent relaxations is under investigated in CC. Concerning EFS-induced relaxation, in the present study 4- AP surprisingly potentiated EFS-induced relaxation responses. The same effect was produced by the non-selective K<sup>&#x0002B;</sup> channels blocker TEA (10<sup>&#x02212;3</sup>M). This potentiatory effect is unexpected since&#x02014;as described by Malysz and co-workers- K<sub>V</sub> currents increased excitation of rabbit CC myocytes, and hence should have enhanced contraction or reduce relaxation (Malysz et al., <xref ref-type="bibr" rid="B36">2002</xref>). Although neither the design of this study nor the dose of 4-AP used targeted the investigation of a potential effect on contraction, the unexpected potentiation of relaxation induced by 4-AP was studied in depth by <italic>in vitro</italic> experiments using rabbit CC and rat anococcygeus muscle- which is part of the erectile machinery in male rodents (Gillespie, <xref ref-type="bibr" rid="B15">1972</xref>). To our knowledge the current study is the first to demonstrate that the blockade of the K<sub>V</sub> channels by 4-AP possess a potentiatory effect on the EFS-induced relaxation responses in rabbit CC. These results are in agreement with studies performed in other tissues including: canine iloecolonic junction (De Man et al., <xref ref-type="bibr" rid="B11">1993</xref>), lamina propria of the female rabbit urethra (Zygmunt et al., <xref ref-type="bibr" rid="B50">1996</xref>), sheep urethra (Costa et al., <xref ref-type="bibr" rid="B8">2001</xref>), and pig urinary bladder neck (Hernandez et al., <xref ref-type="bibr" rid="B20">2008</xref>). All these studies suggested a prejunctional modulatory role of K<sub>V</sub> channels in nitrergic neurotransmission. Since treatment of rabbit CC with 4-AP reduced the SNP-induced relaxation, the latter observation provides further evidence that the potentiation of EFS- induced relaxation by 4-AP is mediated via a pre-junctional and not a post-junctional effect. It is to be mentioned that only the non-selective and 4-AP, the selective K<sub>V</sub> channel blockers potentiated EFS-induced relaxation in contrast to other channels blockers tested.</p>
<p>A hypothesis was put forward by Hernandez et al. (<xref ref-type="bibr" rid="B20">2008</xref>) to explain this potentiation in the pig urinary bladder neck. Arrival of action potentials at the nitrergic nerve terminal evokes membrane depolarization and activation of voltage-gated Ca<sup>2&#x0002B;</sup>channels with the subsequent Ca<sup>2&#x0002B;</sup> influx. Increased cytosolic Ca<sup>2&#x0002B;</sup> stimulates nNOS through interaction with calmodulin, and would favor NO synthesis from L- arginine and release from nerves. In addition to the opening of voltage-gated Ca<sup>2&#x0002B;</sup>channels, an activation of neuronal (pre-junctional) K<sub>V</sub> channels downregulate the NO synthesis, probably through inhibition of voltage-gated Ca<sup>2&#x0002B;</sup>channels, thus increasing the hyperpolarizing post-potential phase (Hernandez et al., <xref ref-type="bibr" rid="B20">2008</xref>). Therefore, the blockade of K<sub>V</sub> channels probably prolong the depolarization phase and hence increase the synthesis of NO and eventually potentiate the EFS-induced relaxation. This hypothesis is supported by the finding that neurons express different types of K<sup>&#x0002B;</sup> channels (Bowery and Smart, <xref ref-type="bibr" rid="B4">2006</xref>). Furthermore, 4-AP has been found to increase neurotransmitter release in the CNS (Tibbs et al., <xref ref-type="bibr" rid="B45">1989</xref>; Schnee and Brown, <xref ref-type="bibr" rid="B43">1998</xref>; Luca and Singer, <xref ref-type="bibr" rid="B35">2013</xref>; Li et al., <xref ref-type="bibr" rid="B32">2016</xref>); an effect that also favors the proposed hypothesis. It is to be mentioned that the compound (4-AP) has been used in many studies of vascular smooth muscle as a K<sub>V</sub> channel blocker in order to separate the K<sub>V</sub> current from (BK<sub>Ca</sub>) current, which is also activated by membrane depolarization (Ko et al., <xref ref-type="bibr" rid="B26">2008</xref>). In this context, the exclusion of the effect of (BK<sub>Ca</sub>) channels by adding iberiotoxin (the selective (BK<sub>Ca</sub>) blocker) to the organ bath, will be of value in future experiments to confirm the proposed role for K<sub>V</sub> channels, since both K<sub>V</sub> and (BK<sub>Ca</sub>) channels are activated by depolarization. It remains to point out that a sustained-release form of 4-AP which is also known by its international non-proprietary name, fampridine has been developed and is currently licensed for the treatment of walking impairment in multiple sclerosis (Krishnan and Kiernan, <xref ref-type="bibr" rid="B28">2013</xref>).</p>
<p>To test if the previous hypothesis applies in rabbit CC, the effect of 4-AP and TEA (10<sup>&#x02212;3</sup>M) on EFS-induced relaxation was tested in the presence of the non-selective NOS inhibitor L-NNA. In this context, the effect of TEA (10<sup>&#x02212;3</sup> M) on EFS-induced relaxation was tested in presence of L-NNA (10<sup>&#x02212;5</sup> M, a dose tested to produce 50% decrease in EFS-induced relaxation). Interestingly, in presence of L-NNA the potentiatory effect of TEA on EFS-induced relaxation was abolished. This was followed by examining the effect of 4-AP in presence of L-NNA. To accomplish this objective and obtain evidence about the proposed theory, this experiment was performed using 3 different protocols. In the first protocol, 4-AP and L-NNA (10<sup>&#x02212;5</sup> M) were added simultaneously to the organ bath and their effect on EFS-induced relaxation was tested according to the method described by Hernandez et al. (<xref ref-type="bibr" rid="B20">2008</xref>). In the second and third protocols, either L- NNA (10<sup>&#x02212;5</sup> M) or (2 &#x000D7; 10<sup>&#x02212;4</sup> M, tested to produce 98% reduction in EFS-induced relaxation) were added to the organ bath followed by testing the effect of 4-AP. In all 3 protocols, 4- AP did not potentiate EFS-induced relaxation responses after NOS blockade, and same observation was observed and confirmed in the anococcygeus muscle which is a part of the erectile machinery in the rat. These results are similar to that obtained by Hernandez et al. (<xref ref-type="bibr" rid="B20">2008</xref>) in the pig urinary bladder neck, which provides evidence that the blockade of neuronal K<sub>V</sub> channels did increase NO synthesis and therefore resulted in the potentiation of EFS-induced relaxation. Consequently, this potentiation was abolished upon the inhibition of NO synthesis by L-NNA. As mentioned earlier in this discussion, 4-AP inhibited ACh-induced relaxation (even more than SNP relaxation); therefore, we cannot rule out the presence of K<sub>V</sub> channels equally in endothelium, the blockade of which may have caused a reduction in synthesis of ACh-dependent relaxing factors. Unlike smooth muscle cells, endothelial cells lack voltage gated Ca<sup>&#x0002B;2</sup> channels and are electrically non-excitable, and hyperpolarization will tend to increase intracellular Ca<sup>&#x0002B;2</sup> concentration by enhancing the electrochemical gradient that drives transmembrane Ca<sup>&#x0002B;2</sup> influx in the endothelium. This increase of intracellular Ca<sup>&#x0002B;2</sup> concentration is critical for the release of endothelial relaxing factors such as NO, EDHF and prostacyclin (Kamouchi et al., <xref ref-type="bibr" rid="B25">1999</xref>; Triggle et al., <xref ref-type="bibr" rid="B46">2012</xref>). Further experiments using specific nNOS inhibitor may be required to further elucidate these results, as well as immunohistochemistry studies to compare localization of K<sub>V</sub> channels between nerves and endothelial smooth muscle cells.</p>
</sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusion</title>
<p>In conclusion, it seems that K<sub>V</sub> channels may have a pre-junctional role in modulating NO synthesis in corpus cavernosum, where their blockade may increase NO synthesis.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>AS contributed to the design of the experiments, their execution, and analysis of data, interpretation of data and discussion of the results as well as to the revision of figures and editing of the manuscript. HA conducted efficiently the organ bath experiments, contributed to the experimental design and analysis of data. She was responsible for the literature review and the original editing of the manuscript. FS contributed to the design of the experiments, interpretation of data and discussion of the results as well as to the revision of figures and the whole manuscript. MM contributed to the development of the original idea of the manuscript, review and analysis of data, interpretation and discussion of the results as well as revision of the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>K. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction</article-title>. <source>Pharmacol. Rev.</source> <volume>63</volume>, <fpage>811</fpage>&#x02013;<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1124/pr.111.004515</pub-id><pub-id pub-id-type="pmid">21880989</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andre</surname> <given-names>E.</given-names></name> <name><surname>Malheiros</surname> <given-names>A.</given-names></name> <name><surname>Cechinel-Filho</surname> <given-names>V.</given-names></name> <name><surname>Yunes</surname> <given-names>R. A.</given-names></name> <name><surname>Calixto</surname> <given-names>J. B.</given-names></name></person-group> (<year>2003</year>). <article-title>Role of nitric oxide and K<sup>&#x0002B;</sup> channels in relaxation induced by polygodial in rabbit corpus cavernosum <italic>in vitro</italic></article-title>. <source>J. Cardiovasc. Pharmacol.</source> <volume>41</volume>, <fpage>300</fpage>&#x02013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1097/00005344-200302000-00020</pub-id><pub-id pub-id-type="pmid">12548092</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Archer</surname> <given-names>S. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Potassium channels and erectile dysfunction</article-title>. <source>Vasc. Pharmacol.</source> <volume>38</volume>, <fpage>61</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S1537-1891(02)00127-1</pub-id><pub-id pub-id-type="pmid">12378824</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowery</surname> <given-names>N. G.</given-names></name> <name><surname>Smart</surname> <given-names>T. G.</given-names></name></person-group> (<year>2006</year>). <article-title>GABA and glycine as neurotransmitters: a brief history</article-title>. <source>Br. J. Pharmacol.</source> <volume>147</volume>(<supplement>Suppl. 1</supplement>), <fpage>S109</fpage>&#x02013;<lpage>S119</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0706443</pub-id><pub-id pub-id-type="pmid">16402094</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname> <given-names>G. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Gap junctions and ion channels: relevance to erectile dysfunction</article-title>. <source>Int. J. Impot. Res.</source> <volume>12</volume>(<supplement>Suppl. 4</supplement>), <fpage>S15</fpage>&#x02013;<lpage>S25</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijir.3900573</pub-id><pub-id pub-id-type="pmid">11035382</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname> <given-names>G. J.</given-names></name></person-group> (<year>2002</year>). <article-title>K channels as molecular targets for the treatment of erectile dysfunction</article-title>. <source>J. Androl.</source> <volume>23</volume>, <fpage>S10</fpage>&#x02013;<lpage>S19</lpage>. <pub-id pub-id-type="doi">10.1002/j.1939-4640.2002.tb02291.x</pub-id><pub-id pub-id-type="pmid">12236168</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname> <given-names>G. J.</given-names></name> <name><surname>Spray</surname> <given-names>D. C.</given-names></name> <name><surname>Brink</surname> <given-names>P. R.</given-names></name></person-group> (<year>1993</year>). <article-title>Characterization of K currents in cultured human corporal smooth muscle cells</article-title>. <source>J. Androl.</source> <volume>14</volume>, <fpage>319</fpage>&#x02013;<lpage>328</lpage>. <pub-id pub-id-type="pmid">7507099</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname> <given-names>G.</given-names></name> <name><surname>Labadia</surname> <given-names>A.</given-names></name> <name><surname>Triguero</surname> <given-names>D.</given-names></name> <name><surname>Jimenez</surname> <given-names>E.</given-names></name> <name><surname>Garcia-Pascual</surname> <given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Nitrergic relaxation in urethral smooth muscle: involvement of potassium channels and alternative redox forms of NO</article-title>. <source>Naunyn Schmiedebergs Arch. Pharmacol.</source> <volume>364</volume>, <fpage>516</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1007/s002100100480</pub-id><pub-id pub-id-type="pmid">11770006</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalaklioglu</surname> <given-names>S.</given-names></name> <name><surname>Ozbey</surname> <given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of different types of potassium channels in the relaxation of corpus cavernosum induced by resveratrol</article-title>. <source>Pharmacogn. Mag.</source> <volume>10</volume>, <fpage>47</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.4103/0973-1296.126658</pub-id><pub-id pub-id-type="pmid">24696545</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalaklioglu-Tasatargil</surname> <given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Characterization of the relaxant response to taurine in rat corpus cavernosum</article-title>. <source>Pharmacology</source> <volume>91</volume>, <fpage>243</fpage>&#x02013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1159/000348574</pub-id><pub-id pub-id-type="pmid">23615068</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Man</surname> <given-names>J. G.</given-names></name> <name><surname>Boeckxstaens</surname> <given-names>G. E.</given-names></name> <name><surname>Pelckmans</surname> <given-names>P. P.</given-names></name> <name><surname>De Winter</surname> <given-names>B. Y.</given-names></name> <name><surname>Herman</surname> <given-names>A. G.</given-names></name> <name><surname>Van Maercke</surname> <given-names>Y. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Prejunctional modulation of the nitrergic innervation of the canine ileocolonic junction via potassium channels</article-title>. <source>Br. J. Pharmacol.</source> <volume>110</volume>, <fpage>559</fpage>&#x02013;<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1993.tb13847.x</pub-id><pub-id pub-id-type="pmid">8242230</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname> <given-names>F. M.</given-names></name> <name><surname>Ribeiro</surname> <given-names>R. F.</given-names> <suffix>Jr.</suffix></name> <name><surname>Fernandes</surname> <given-names>A. A.</given-names></name> <name><surname>Fiorim</surname> <given-names>J.</given-names></name> <name><surname>Travaglia</surname> <given-names>T. C.</given-names></name> <name><surname>Vassallo</surname> <given-names>D. V.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Na<sup>&#x0002B;</sup>/K<sup>&#x0002B;</sup>-ATPase activity and K<sup>&#x0002B;</sup> channels differently contribute to vascular relaxation in male and female rats</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e106345</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0106345</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>S. F.</given-names></name> <name><surname>Brink</surname> <given-names>P. R.</given-names></name> <name><surname>Melman</surname> <given-names>A.</given-names></name> <name><surname>Christ</surname> <given-names>G. J.</given-names></name></person-group> (<year>1995</year>). <article-title>An analysis of the Maxi-K<sup>&#x0002B;</sup> (KCa) channel in cultured human corporal smooth muscle cells</article-title>. <source>J. Urol.</source> <volume>153</volume>, <fpage>818</fpage>&#x02013;<lpage>825</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(01)67729-2</pub-id><pub-id pub-id-type="pmid">7861546</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiorim</surname> <given-names>J.</given-names></name> <name><surname>Ribeiro</surname> <given-names>R. F.</given-names> <suffix>Jr.</suffix></name> <name><surname>Azevedo</surname> <given-names>B. F.</given-names></name> <name><surname>Simoes</surname> <given-names>M. R.</given-names></name> <name><surname>Padilha</surname> <given-names>A. S.</given-names></name> <name><surname>Stefanon</surname> <given-names>I.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Activation of K<sup>&#x0002B;</sup> channels and Na<sup>&#x0002B;</sup>/K<sup>&#x0002B;</sup> ATPase prevents aortic endothelial dysfunction in 7-day lead-treated rats</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>262</volume>, <fpage>22</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.taap.2012.04.015</pub-id><pub-id pub-id-type="pmid">22546088</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname> <given-names>J. S.</given-names></name></person-group> (<year>1972</year>). <article-title>The rat anococcygeus muscle and its response to nerve stimulation and to some drugs</article-title>. <source>Br. J. Pharmacol.</source> <volume>45</volume>, <fpage>404</fpage>&#x02013;<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1972.tb08097.x</pub-id><pub-id pub-id-type="pmid">5072226</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname> <given-names>M.</given-names></name> <name><surname>Shieh</surname> <given-names>C. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Potassium channel subtypes as molecular targets for overactive bladder and other urological disorders</article-title>. <source>Expert Opin. Ther. Targets</source> <volume>8</volume>, <fpage>437</fpage>&#x02013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1517/14728222.8.5.437</pub-id><pub-id pub-id-type="pmid">15469394</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gratzke</surname> <given-names>C.</given-names></name> <name><surname>Angulo</surname> <given-names>J.</given-names></name> <name><surname>Chitaley</surname> <given-names>K.</given-names></name> <name><surname>Dai</surname> <given-names>Y. T.</given-names></name> <name><surname>Kim</surname> <given-names>N. N.</given-names></name> <name><surname>Paick</surname> <given-names>J. S.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Anatomy, physiology, and pathophysiology of erectile dysfunction</article-title>. <source>J. Sex. Med.</source> <volume>7</volume>, <fpage>445</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2009.01624.x</pub-id><pub-id pub-id-type="pmid">20092448</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>D. H.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name> <name><surname>Kim</surname> <given-names>H.</given-names></name> <name><surname>Ko</surname> <given-names>M. K.</given-names></name> <name><surname>Chae</surname> <given-names>M. R.</given-names></name> <name><surname>Kim</surname> <given-names>H. K.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Effects of <italic>Schisandra chinensis</italic> extract on the contractility of corpus cavernosal smooth muscle (CSM) and Ca<sup>2&#x0002B;</sup> homeostasis in CSM cells</article-title>. <source>BJU Int.</source> <volume>109</volume>, <fpage>1404</fpage>&#x02013;<lpage>1413</lpage>. <pub-id pub-id-type="doi">10.1111/j.1464-410x.2011.10567.x</pub-id><pub-id pub-id-type="pmid">21951618</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hannigan</surname> <given-names>K. I.</given-names></name> <name><surname>Large</surname> <given-names>R. J.</given-names></name> <name><surname>Bradley</surname> <given-names>E.</given-names></name> <name><surname>Hollywood</surname> <given-names>M. A.</given-names></name> <name><surname>Sergeant</surname> <given-names>G. P.</given-names></name> <name><surname>McHale</surname> <given-names>N. G.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Effect of a novel BK<sub>Ca</sub> opener on BK<sub>Ca</sub> currents and contractility of the rabbit corpus cavernosum</article-title>. <source>Am. J. Physiol. Cell Physiol.</source> <volume>310</volume>, <fpage>C284</fpage>&#x02013;<lpage>C292</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00273.2015</pub-id><pub-id pub-id-type="pmid">26659726</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname> <given-names>M.</given-names></name> <name><surname>Barahona</surname> <given-names>M. V.</given-names></name> <name><surname>Recio</surname> <given-names>P.</given-names></name> <name><surname>Navarro-Dorado</surname> <given-names>J.</given-names></name> <name><surname>Bustamante</surname> <given-names>S.</given-names></name> <name><surname>Benedito</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Role of neuronal voltage-gated K<sup>&#x0002B;</sup> channels in the modulation of the nitrergic neurotransmission of the pig urinary bladder neck</article-title>. <source>Br. J. Pharmacol.</source> <volume>153</volume>, <fpage>1251</fpage>&#x02013;<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0707669</pub-id><pub-id pub-id-type="pmid">18223671</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmquist</surname> <given-names>F.</given-names></name> <name><surname>Andersson</surname> <given-names>K. E.</given-names></name> <name><surname>Fovaeus</surname> <given-names>M.</given-names></name> <name><surname>Hedlund</surname> <given-names>H.</given-names></name></person-group> (<year>1990</year>). <article-title>K<sup>&#x0002B;</sup>-channel openers for relaxation of isolated penile erectile tissue from rabbit</article-title>. <source>J. Urol.</source> <volume>144</volume>, <fpage>146</fpage>&#x02013;<lpage>151</lpage>. <pub-id pub-id-type="pmid">2359166</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname> <given-names>E. S.</given-names></name> <name><surname>Dart</surname> <given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuronal and cardiovascular potassium channels as therapeutic drug targets: promise and pitfalls</article-title>. <source>J. Biomol. Screen.</source> <volume>20</volume>, <fpage>1055</fpage>&#x02013;<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1177/1087057115601677</pub-id><pub-id pub-id-type="pmid">26303307</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Insuk</surname> <given-names>S. O.</given-names></name> <name><surname>Chae</surname> <given-names>M. R.</given-names></name> <name><surname>Choi</surname> <given-names>J. W.</given-names></name> <name><surname>Yang</surname> <given-names>D. K.</given-names></name> <name><surname>Sim</surname> <given-names>J. H.</given-names></name> <name><surname>Lee</surname> <given-names>S. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Molecular basis and characteristics of K<sub>ATP</sub> channel in human corporal smooth muscle cells</article-title>. <source>Int. J. Impot. Res.</source> <volume>15</volume>, <fpage>258</fpage>&#x02013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijir.3901013</pub-id><pub-id pub-id-type="pmid">12934053</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jepps</surname> <given-names>T. A.</given-names></name> <name><surname>Olesen</surname> <given-names>S. P.</given-names></name> <name><surname>Greenwood</surname> <given-names>I. A.</given-names></name> <name><surname>Dalsgaard</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>Molecular and functional characterization of K<sub>V</sub> 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats</article-title>. <source>Br. J. Pharmacol.</source> <volume>173</volume>, <fpage>1478</fpage>&#x02013;<lpage>1490</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13444</pub-id><pub-id pub-id-type="pmid">26802314</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamouchi</surname> <given-names>M.</given-names></name> <name><surname>Droogmans</surname> <given-names>G.</given-names></name> <name><surname>Nilius</surname> <given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>Membrane potential as a modulator of the free intracellular Ca<sup>2&#x0002B;</sup> concentration in agonist-activated endothelial cells</article-title>. <source>Gen. Physiol. Biophys.</source> <volume>18</volume> <fpage>199</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="pmid">10517293</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>E. A.</given-names></name> <name><surname>Han</surname> <given-names>J.</given-names></name> <name><surname>Jung</surname> <given-names>I. D.</given-names></name> <name><surname>Park</surname> <given-names>W. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Physiological roles of K<sup>&#x0002B;</sup> channels in vascular smooth muscle cells</article-title>. <source>J. Smooth Muscle Res.</source> <volume>44</volume>, <fpage>65</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1540/jsmr.44.65</pub-id><pub-id pub-id-type="pmid">18552454</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>E. A.</given-names></name> <name><surname>Park</surname> <given-names>W. S.</given-names></name> <name><surname>Firth</surname> <given-names>A. L.</given-names></name> <name><surname>Kim</surname> <given-names>N.</given-names></name> <name><surname>Yuan</surname> <given-names>J. X.</given-names></name> <name><surname>Han</surname> <given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Pathophysiology of voltage-gated K<sup>&#x0002B;</sup> channels in vascular smooth muscle cells: modulation by protein kinases</article-title>. <source>Prog. Biophys. Mol. Biol.</source> <volume>103</volume>, <fpage>95</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2009.10.001</pub-id><pub-id pub-id-type="pmid">19835907</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname> <given-names>A. V.</given-names></name> <name><surname>Kiernan</surname> <given-names>M. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis</article-title>. <source>Mult. Scler.</source> <volume>19</volume>, <fpage>385</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1177/1352458512463769</pub-id><pub-id pub-id-type="pmid">23077091</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>W. S.</given-names></name> <name><surname>Ramkumar</surname> <given-names>V.</given-names></name> <name><surname>el-Fakahany</surname> <given-names>E. E.</given-names></name></person-group> (<year>1985</year>). <article-title>Possible allosteric interaction of 4-aminopyridine with rat brain muscarinic acetylcholine receptors</article-title>. <source>J. Neurochem.</source> <volume>44</volume>, <fpage>1936</fpage>&#x02013;<lpage>1942</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1985.tb07190.x</pub-id><pub-id pub-id-type="pmid">2580955</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Physiological roles and properties of potassium channels in corporal smooth muscle</article-title>. <source>Drugs Today (Barc)</source> <volume>36</volume>, <fpage>147</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1358/dot.2000.36.2-3.568788</pub-id><pub-id pub-id-type="pmid">12879112</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S. W.</given-names></name> <name><surname>Wang</surname> <given-names>H. Z.</given-names></name> <name><surname>Christ</surname> <given-names>G. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of ATP-sensitive potassium channels in human corporal smooth muscle cells</article-title>. <source>Int. J. Impot. Res.</source> <volume>11</volume>, <fpage>179</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijir.3900398</pub-id><pub-id pub-id-type="pmid">10467517</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Liu</surname> <given-names>Z. L.</given-names></name> <name><surname>Zhang</surname> <given-names>W. N.</given-names></name> <name><surname>Yang</surname> <given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Blockade of presynaptic 4- aminopyridine-sensitive potassium channels increases initial neurotransmitter release probability, reinstates synaptic transmission altered by GABAB receptor activation in rat midbrain periaqueductal gray</article-title>. <source>Neuroreport</source> <volume>27</volume>, <fpage>50</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1097/wnr.0000000000000499</pub-id><pub-id pub-id-type="pmid">26575285</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="web"><person-group person-group-type="author"><name><surname>Lily Jan</surname> <given-names>B. A. Y.</given-names></name> <name><surname>Jeanne N Michael S. C James Trimmer</surname> <given-names>S.</given-names></name> <name><surname>George Chandy</surname> <given-names>K.</given-names></name> <name><surname>Stephan</surname> <given-names>G.</given-names></name> <etal/></person-group> (<year>2016</year>). <source>Voltage-Gated Potassium Channels. IUPHAR/BPS Guide Topharmacology</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=81">http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=81</ext-link> (Accessed July 07, 2016).</citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>C. S.</given-names></name> <name><surname>Lin</surname> <given-names>G.</given-names></name> <name><surname>Lue</surname> <given-names>T. F.</given-names></name></person-group> (<year>2005</year>). <article-title>Cyclic nucleotide signaling in cavernous smooth muscle</article-title>. <source>J. Sex. Med.</source> <volume>2</volume>, <fpage>478</fpage>&#x02013;<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1111/j.1743-6109.2005.00080.x</pub-id><pub-id pub-id-type="pmid">16422842</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luca</surname> <given-names>C. C.</given-names></name> <name><surname>Singer</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Can 4-aminopyridine modulate dysfunctional gait networks in Parkinson&#x00027;s disease?</article-title>. <source>Parkinsonism Relat. Disord.</source> <volume>19</volume>, <fpage>777</fpage>&#x02013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.04.024</pub-id><pub-id pub-id-type="pmid">23706539</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malysz</surname> <given-names>J.</given-names></name> <name><surname>Farrugia</surname> <given-names>G.</given-names></name> <name><surname>Ou</surname> <given-names>Y.</given-names></name> <name><surname>Szurszewski</surname> <given-names>J. H.</given-names></name> <name><surname>Nehra</surname> <given-names>A.</given-names></name> <name><surname>Gibbons</surname> <given-names>S. J.</given-names></name></person-group> (<year>2002</year>). <article-title>The Kv2.2 &#x003B1;subunit contributes to delayed rectifier K<sup>&#x0002B;</sup> currents in myocytes from rabbit corpus cavernosum</article-title>. <source>J. Androl.</source> <volume>23</volume>, <fpage>899</fpage>&#x02013;<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1002/j.1939-4640.2002.tb02348.x</pub-id><pub-id pub-id-type="pmid">12399537</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malysz</surname> <given-names>J.</given-names></name> <name><surname>Gibbons</surname> <given-names>S. J.</given-names></name> <name><surname>Miller</surname> <given-names>S. M.</given-names></name> <name><surname>Gettman</surname> <given-names>M.</given-names></name> <name><surname>Nehra</surname> <given-names>A.</given-names></name> <name><surname>Szurszewski</surname> <given-names>J. H.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Potassium outward currents in freshly dissociated rabbit corpus cavernosum myocytes</article-title>. <source>J. Urol.</source> <volume>166</volume>, <fpage>1167</fpage>&#x02013;<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)65940-X</pub-id><pub-id pub-id-type="pmid">11490317</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname> <given-names>D. G.</given-names></name> <name><surname>Byun</surname> <given-names>H. S.</given-names></name> <name><surname>Kim</surname> <given-names>J. J.</given-names></name></person-group> (<year>1999</year>). <article-title>A K<sub>ATP</sub>-channel opener as a potential treatment modality for erectile dysfunction</article-title>. <source>BJU Int.</source> <volume>83</volume>, <fpage>837</fpage>&#x02013;<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1046/j.1464-410x.1999.00029.x</pub-id><pub-id pub-id-type="pmid">10368209</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Musicki</surname> <given-names>B.</given-names></name> <name><surname>Ross</surname> <given-names>A. E.</given-names></name> <name><surname>Champion</surname> <given-names>H. C.</given-names></name> <name><surname>Burnett</surname> <given-names>A. L.</given-names></name> <name><surname>Bivalacqua</surname> <given-names>T. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Posttranslational modification of constitutive nitric oxide synthase in the penis</article-title>. <source>J. Androl.</source> <volume>30</volume>, <fpage>352</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.2164/jandrol.108.006999</pub-id><pub-id pub-id-type="pmid">19342700</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname> <given-names>P. W.</given-names></name> <name><surname>de Sousa</surname> <given-names>G. J.</given-names></name> <name><surname>Caliman</surname> <given-names>I. F.</given-names></name> <name><surname>Lamas</surname> <given-names>A. Z.</given-names></name> <name><surname>Santos de Medeiros</surname> <given-names>A. R.</given-names></name> <name><surname>de Andrade</surname> <given-names>T. U.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Metformin ameliorates ovariectomy-induced vascular dysfunction in non-diabetic Wistar rats</article-title>. <source>Clin. Sci. (Lond)</source> <volume>127</volume>, <fpage>265</fpage>&#x02013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1042/CS20130553</pub-id><pub-id pub-id-type="pmid">24521306</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prieto</surname> <given-names>D.</given-names></name></person-group> (<year>2008</year>). <article-title>Physiological regulation of penile arteries and veins</article-title>. <source>Int. J. Impot. Res.</source> <volume>20</volume>, <fpage>17</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijir.3901581</pub-id><pub-id pub-id-type="pmid">17637789</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Satake</surname> <given-names>N.</given-names></name> <name><surname>Shibata</surname> <given-names>M.</given-names></name> <name><surname>Shibata</surname> <given-names>S.</given-names></name></person-group> (<year>1997</year>). <article-title>The involvement of KCa, K<sub>ATP</sub> and K<sub>V</sub> channels in vasorelaxing responses to acetylcholine in rat aortic rings</article-title>. <source>Gen. Pharmacol.</source> <volume>28</volume>, <fpage>453</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-3623(96)00238-8</pub-id><pub-id pub-id-type="pmid">9068990</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schnee</surname> <given-names>M. E.</given-names></name> <name><surname>Brown</surname> <given-names>B. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium- activated potassium currents in hippocampal neurons</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>286</volume> <fpage>709</fpage>&#x02013;<lpage>717</lpage>. <pub-id pub-id-type="pmid">9694925</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stott</surname> <given-names>J. B.</given-names></name> <name><surname>Jepps</surname> <given-names>T. A.</given-names></name> <name><surname>Greenwood</surname> <given-names>I. A.</given-names></name></person-group> (<year>2014</year>). <article-title>KV7 potassium channels: a new therapeutic target in smooth muscle disorders</article-title>. <source>Drug Discov. Today</source> <volume>19</volume>, <fpage>413</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2013.12.003</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tibbs</surname> <given-names>G. R.</given-names></name> <name><surname>Dolly</surname> <given-names>J. O.</given-names></name> <name><surname>Nicholls</surname> <given-names>D. G.</given-names></name></person-group> (<year>1989</year>). <article-title>Dendrotoxin, 4-aminopyridine, and &#x003B2;-bungarotoxin act at common loci but by two distinct mechanisms to induce Ca<sup>2&#x0002B;</sup>-dependent release of glutamate from guinea-pig cerebrocortical synaptosomes</article-title>. <source>J Neurochem.</source> <volume>52</volume>, <fpage>201</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1989.tb10917.x</pub-id><pub-id pub-id-type="pmid">2562805</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Triggle</surname> <given-names>C. R.</given-names></name> <name><surname>Samuel</surname> <given-names>S. M.</given-names></name> <name><surname>Ravishankar</surname> <given-names>S.</given-names></name> <name><surname>Marei</surname> <given-names>I.</given-names></name> <name><surname>Arunachalam</surname> <given-names>G.</given-names></name> <name><surname>Ding</surname> <given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>The endothelium: influencing vascular smooth muscle in many ways</article-title>. <source>Can. J. Physiol. Pharmacol.</source> <volume>90</volume>, <fpage>713</fpage>&#x02013;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1139/y2012-073</pub-id><pub-id pub-id-type="pmid">22625870</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H. Z.</given-names></name> <name><surname>Lee</surname> <given-names>S. W.</given-names></name> <name><surname>Christ</surname> <given-names>G. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Comparative studies of the maxi-K (KCa) channel in freshly isolated myocytes of human and rat corpora</article-title>. <source>Int. J. Impot. Res.</source> <volume>12</volume>, <fpage>9</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijir.3900444</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname> <given-names>M. E.</given-names></name> <name><surname>Zvara</surname> <given-names>P.</given-names></name> <name><surname>Meredith</surname> <given-names>A. L.</given-names></name> <name><surname>Aldrich</surname> <given-names>R. W.</given-names></name> <name><surname>Nelson</surname> <given-names>M. T.</given-names></name></person-group> (<year>2005</year>). <article-title>Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel</article-title>. <source>J. Physiol.</source> <volume>567</volume>, <fpage>545</fpage>&#x02013;<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2005.093823</pub-id><pub-id pub-id-type="pmid">16020453</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname> <given-names>H.</given-names></name> <name><surname>Castle</surname> <given-names>N. A.</given-names></name> <name><surname>Pardo</surname> <given-names>L. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Voltage-gated potassium channels as therapeutic targets</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>8</volume>, <fpage>982</fpage>&#x02013;<lpage>1001</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2983</pub-id><pub-id pub-id-type="pmid">19949402</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zygmunt</surname> <given-names>P. K.</given-names></name> <name><surname>Hogestatt</surname> <given-names>E. D.</given-names></name> <name><surname>Andersson</surname> <given-names>K. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Effects of potassium channel inhibitors on nitrergic and adrenergic neurotransmission in lamina propria of the female rabbit urethra</article-title>. <source>Naunyn Schmiedeberg Arch. Pharmacol.</source> <volume>354</volume>, <fpage>336</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1007/BF00171065</pub-id><pub-id pub-id-type="pmid">8878064</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was funded by the Faculty of Pharmacy, Alexandria University, Egypt.</p>
</fn>
</fn-group>
</back>
</article>